Leukemia Research
Volume 34, Issue 4 , Pages 413-415 , April 2010

Adding FISH to karyotype in Myelodysplastic syndrome investigation diagnosis: Are all questions answered?

Received 5 October 2009

References 

  1. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JCY, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev/Cancer. 2007;7:118–129
  2. Lorand-Metze I, Pinheiro MP, Ribeiro E, Paula EV, Metze K. Factors influencing survival in Myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res. 2004;28:587–594
  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the Myelodysplastic syndromes. Br J Haematol. 1982;51:189–199
  4. In:  Swerdlow SH,  Campo E,  Harris NL,  Jaffe ES,  Pileri SA,  Stein H,  Thiele J,  Vardiman JW editor. WHO Classification of tumours and lymphoid tissues. IARC Lyon; 2008;
  5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in Myelodysplastic syndromes. Blood. 1997;89:2079–2088
  6. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in Myelodysplastic syndromes. J Clin Oncol. 2007;25:3503–3510
  7. Malcovati L, Nimer SD. Myelodysplastic syndromes: diagnosis and staging. Cancer Control. 2008;15(suppl. 4–13):
  8. Solé F, Luño E, Sanzo C, Espinet B, Sanz GF, Cervera J, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary Myelodysplastic syndromes. Haematologica. 2005;90:1168–1178
  9. Haase D. Cytogenetics features in Myelodysplastic syndromes. Ann Hematol. 2008;87:515–526
  10. Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, et al. Definitions and standards in the diagnosis and treatment of the Myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res. 2007;31(6):727–736
  11. ISCN . In:  Shaffer LG,  Slovak ML,  Campbell LJ editor. An international system for human cytogenetics nomenclature. Basel: S. Karger; 2009;
  12. Bernasconi P, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, et al. Clinical relevance of cytogenetics in Myelodysplastic syndromes. Ann N Y Acad Sci. 2006;1089:395–410
  13. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, et al. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med. 2006;8(1):16–23
  14. Romeo M, Chauffaille MLLF, Silva MRR, Bahia DM, Kerbauy J. Comparison of cytogenetics with FISH in 40 Myelodysplastic syndrome patients. Leuk Res. 2002;26(11):993–996
  15. Panani AD, Pappa V. Hidden chromosome 8 abnormalities detected by FISH in adults primary Myelodysplastic syndromes. In Vivo. 2005;19(6):979–981
  16. Rigolin GM, Bigoni R, Milani R, Cavazzini F, Roberti MG, Bardi A, et al. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in Myelodysplastic syndromes with normal karyotype. Leukemia. 2001;15(12):1841–1847
  17. Bernasconi P, Cavilgiano PM, Boni M, Calatroni S, Giardini I, Rocca B, et al. Is FISH a relevant prognostic tool in Myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia. 2003;17:2107–2112
  18. Cherry AM, Brockman SR, Paternoster SF, Hicks GA, Neuberg D, Higgins RR, et al. Comparison of interphase FISH and metaphase cytogenetics to study Myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leuk Res. 2003;27(12):1085–1090
  19. Pinheiro RF, Chauffaille MLLF. Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of Myelodysplastic syndrome. Braz J Med Biol Res. 2009;42(11):1110–1112
  20. Steema DP, List AF. Genetic testing in the Myelodysplastic syndromes. Mayo Clin Proc. 2005;80(5):681–698
  21. Slovak ML, Dewald GW. International Working group on Myelodysplastic syndrome cytogenetics, Oct 2007 Meeting. Report Leuk Res. 2008;32:1329–1332
  22. Maciejewski JP, Mufti GJ. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood. 2008;112:974–985

PII: S0145-2126(09)00504-9

doi: 10.1016/j.leukres.2009.10.011

Leukemia Research
Volume 34, Issue 4 , Pages 413-415 , April 2010

Article Tools